FUNDACION CIENTIFICA DE LA ASOCIACIÓN ESPANOLA CONTRA EL CANCER - ES 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 11.907.821 466.813 2
2021 0 10.949.936 256.827 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ADELIS1
ALIRA HEALTH SL1
ALLEANZA CONTRO IL CANCRO1
ALTHAIA XARXA ASSISTENCIAL UNIVERSITARIA DE MANRESA FUNDACIO PRIVADA1
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG1
CANADIAN INSTITUTES OF HEALTH RESEARCH1
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD1
CENTRE DE REGULACIO GENOMICA1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
DEUTSCHES ZENTRUM FUR LUFT UND RAUMFAHRT EV1
EFIIS SISTEMIKI VIOLOGIA MONOPROSOPI IKE1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
EUROPEAN ASSOCIATION FOR CANCER RESEARCH1
EUROPEAN CANCER PATIENT COALITION1
FONDATION ARC POUR LA RECHERCHE SUR LE CANCER1
FONDAZIONE REGIONALE PER LA RICERCA BIOMEDICA1
FONDS DE LA RECHERCHE SCIENTIFIQUE FNRS1
FONDS VOOR WETENSCHAPPELIJK ONDERZOEKVLAANDEREN1
FONDS ZUR FOERDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG1
FUNDACAO PARA A CIENCIA E A TECNOLOGIA1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DOCTOR JOSEP TRUETA1
FUNDACIO INSTITUT DE RECERCA BIOMEDICA1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
FUNDACION PARA EL FOMENTO EN ASTURIAS DE LA INVESTIGACION CIENTIFICA APLICADA Y TECNOLOGIA1
FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD MP1
FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III1
GENIKI GRAMMATIA EREVNAS KAI KAINOTOMIAS1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT1
INSTITUT CATALA D'ONCOLOGIA1
INSTITUT GUSTAVE ROUSSY1
INSTITUT NATIONAL DU CANCER GIP1
INSTITUTO DE SALUD CARLOS III1
ISTITUTO SUPERIORE DI SANITA1
KLINIKUM DER UNIVERSITAET ZU KOELN1
KREFTFORENINGEN1
LATVIJAS ZINATNES PADOME1
LEAD DISCOVERY CENTER1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
MINISTERO DEL LAVORO DELLA SALUTE E DELLE POLITICHE SOCIALI1
MINISTERO DELL'UNIVERSITA E DELLA RICERCA1
MINISTRY OF HEALTH1
NARODOWE CENTRUM BADAN I ROZWOJU1
NATIONAL SCIENCE AND TECHNOLOGY COUNCIL1
NEMZETI KUTATASI FEJLESZTESI ES INNOVACIOS HIVATAL1
NORGES FORSKNINGSRAD1
PRISMA ASOCIACION PARA LA DIVERSIDAD AFECTIVOSEXUAL Y DE GENERO EN CIENCIA TECNOLOGIA E INNOVACION1
REGIONE TOSCANA1
SCIENSEED SL1
SERVICIO ANDALUZ DE SALUD1
SIHTASUTUS EESTI TEADUSAGENTUUR1
SLOVENSKA AKADEMIA VIED1
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS1
THE HEALTH RESEARCH BOARD1
THE UNIVERSITY OF MANCHESTER1
TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU1
UBIQ BIO BV1
UNITATEA EXECUTIVA PENTRU FINANTAREA INVATAMANTULUI SUPERIOR A CERCETARII DEZVOLTARII SI INOVARII1
UNIVERSIDAD AUTONOMA DE MADRID1
UNIVERSIDAD DE SEVILLA1
UNIVERSIDAD INTERNACIONAL DE ANDALUCIA1
UNIVERSITAET ZUERICH1
UNIVERSITAETSKLINIKUM AACHEN1
UNIVERSITE DE MONTPELLIER1
UNIVERSITY OF COPENHAGEN1
UNIVERSITY OF PATRAS1
VALSTS IZGLITIBAS ATTISTIBAS AGENTURA1

Constancy:

Total number of partners: 67
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 67
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-11-01Data-driven cancer genome interpretation for personalised cancer treatment CGI-Clinicsparticipant9.257.50817
2022-10-01DNA replication at the heart of cell fate decisions and cancer development RepliFateparticipant2.650.31321
2021-03-01ERA-NET: Sustained collaboration of national and regional programmes in cancer research TRANSCAN-3participant10.949.93632